Reuters logo
BRIEF-Yichang HEC Changjiang Pharmaceutical gets clinical approvals from CFDA
May 4, 2017 / 4:48 AM / 5 months ago

BRIEF-Yichang HEC Changjiang Pharmaceutical gets clinical approvals from CFDA

May 4 (Reuters) - Yichang Hec Changjiang Pharmaceutical Co Ltd

* Clinical approvals successfully obtained from CFDA for insulin aspart drug substance and product Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below